Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • lg36
    Member
    • Mar 2012
    • 12

    Please Help - SNP Calling in relation to Consensus Sequence Quality

    Dear All,

    I've posted on this before and attracted no interest at all. So I'd be very grateful to get your opinions. I'm relatively new to NGS sequence analysis so apologies for any naive assumptions.

    As I understand (perhaps misunderstand) if a SNP is deemed to be present (after all the applied SNP filters, scores etc) then (most of the time) it will appear in the consensus sequence???

    Is it therefore right to think if the consensus sequence is of a 'higher quality', the SNP's too will be of a 'higher quality'??

    I'm defining quality of the consensus by the ability to reflect the presence or absence of certain oligonucleotides that we know to be there from PCR studies in the lab.

    What I'm doing at the moment is trying to set the parameters correctly (paired end width, etc) in order to reach a consensus sequence that is correct according to what we know in the lab. Then I was planning on calling the SNPs based on the mapped reads we used for the best consensus sequence. Is there any validity at all in this approach, or are the two things SNP calling and consensus sequence production too 'unlinked' to make it invalid????

    Many thanks in advance, apologies for any misconceptions

    lg36
  • pag
    Member
    • May 2012
    • 72

    #2
    Most base callers either call "n" at SNP location or pick one or the other (combination of sharpest peak and highest peak as scaled to average intensity for that base). Very few use IUPAC ambiguity codes to convey the potential difference. Quality for those locations, assuming an unbiased amplification level should be approximately 1/2 of the surrounding bases (I believe it's linearly scaled at least). So, if scripts don't already exist, you should be able to compare quality from one base to the neighboring two bases and see if the qual is significantly lower. Then you look at the trace itself (if available) to see if this is a potential SNP.

    It's more difficult if it's a "chimera" or extended polymorphism or if there's a "frameshift."

    I'd be interested to know if there are any chimera/SNP deconvolver programs or scripts out there for use that I can supply the reference sequence and it can let me know the alternate read. I was staring at at two overlapping reads that were significantly out-of-phase with each other yesterday and made about 50 base calls manually over an hour or two. Hardly the model of efficiency

    Comment

    • lg36
      Member
      • Mar 2012
      • 12

      #3
      Thanks pag for your help. So, is it true to say if I can replicate what we know to be the reality of the consensus sequence (from our lab findings), then the SNPs that are output from the same mapped reads will be more reliable?

      Comment

      Latest Articles

      Collapse

      • mylaser
        Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by mylaser
        Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
        If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
        This guide explains everything you need to know about...
        Today, 01:13 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...